246 related articles for article (PubMed ID: 28082117)
41. Inhibition of angiogenesis: a novel antitumor mechanism of the herbal compound arctigenin.
Gu Y; Scheuer C; Feng D; Menger MD; Laschke MW
Anticancer Drugs; 2013 Sep; 24(8):781-91. PubMed ID: 23744558
[TBL] [Abstract][Full Text] [Related]
42. Activation of the metabolic sensor-AMP activated protein kinase reverses impairment of angiogenesis in aging myocardial microvascular endothelial cells. Implications for the aging heart.
Ahluwalia A; Tarnawski AS
J Physiol Pharmacol; 2011 Oct; 62(5):583-7. PubMed ID: 22204807
[TBL] [Abstract][Full Text] [Related]
43. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
Hagedorn M; Zilberberg L; Wilting J; Canron X; Carrabba G; Giussani C; Pluderi M; Bello L; Bikfalvi A
Cancer Res; 2002 Dec; 62(23):6884-90. PubMed ID: 12460903
[TBL] [Abstract][Full Text] [Related]
44. Ferulic Acid Exerts Anti-Angiogenic and Anti-Tumor Activity by Targeting Fibroblast Growth Factor Receptor 1-Mediated Angiogenesis.
Yang GW; Jiang JS; Lu WQ
Int J Mol Sci; 2015 Oct; 16(10):24011-31. PubMed ID: 26473837
[TBL] [Abstract][Full Text] [Related]
45. Both hydrogen peroxide and transforming growth factor beta 1 contribute to endothelial Nox4 mediated angiogenesis in endothelial Nox4 transgenic mouse lines.
Chen L; Xiao J; Kuroda J; Ago T; Sadoshima J; Cohen RA; Tong X
Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2489-99. PubMed ID: 25315297
[TBL] [Abstract][Full Text] [Related]
46. Anti-angiogenic effects of VEGF stimulation on endothelium deficient in phosphoinositide recycling.
Stratman AN; Farrelly OM; Mikelis CM; Miller MF; Wang Z; Pham VN; Davis AE; Burns MC; Pezoa SA; Castranova D; Yano JJ; Kilts TM; Davis GE; Gutkind JS; Weinstein BM
Nat Commun; 2020 Mar; 11(1):1204. PubMed ID: 32139674
[TBL] [Abstract][Full Text] [Related]
47. Hydrogen sulphide and angiogenesis: mechanisms and applications.
Szabó C; Papapetropoulos A
Br J Pharmacol; 2011 Oct; 164(3):853-65. PubMed ID: 21198548
[TBL] [Abstract][Full Text] [Related]
48. Delta-like 4/Notch signaling and its therapeutic implications.
Yan M; Plowman GD
Clin Cancer Res; 2007 Dec; 13(24):7243-6. PubMed ID: 18094402
[TBL] [Abstract][Full Text] [Related]
49. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis.
Mehta VB; Zhou Y; Radulescu A; Besner GE
Growth Factors; 2008 Dec; 26(6):301-15. PubMed ID: 18925469
[TBL] [Abstract][Full Text] [Related]
50. In vitro models of angiogenesis.
Ucuzian AA; Greisler HP
World J Surg; 2007 Apr; 31(4):654-63. PubMed ID: 17372665
[TBL] [Abstract][Full Text] [Related]
51. A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology.
Tate CM; Mc Entire J; Pallini R; Vakana E; Wyss L; Blosser W; Ricci-Vitiani L; D'Alessandris QG; Morgante L; Giannetti S; Larocca LM; Todaro M; Benfante A; Colorito ML; Stassi G; De Maria R; Rowlinson S; Stancato L
PLoS One; 2015; 10(4):e0125697. PubMed ID: 25919028
[TBL] [Abstract][Full Text] [Related]
52. Angiogenesis and the role of the endothelial nicotinic acetylcholine receptor.
Cooke JP
Life Sci; 2007 May; 80(24-25):2347-51. PubMed ID: 17383685
[TBL] [Abstract][Full Text] [Related]
53. SKLB1002, a novel potent inhibitor of VEGF receptor 2 signaling, inhibits angiogenesis and tumor growth in vivo.
Zhang S; Cao Z; Tian H; Shen G; Ma Y; Xie H; Liu Y; Zhao C; Deng S; Yang Y; Zheng R; Li W; Zhang N; Liu S; Wang W; Dai L; Shi S; Cheng L; Pan Y; Feng S; Zhao X; Deng H; Yang S; Wei Y
Clin Cancer Res; 2011 Jul; 17(13):4439-50. PubMed ID: 21622720
[TBL] [Abstract][Full Text] [Related]
54. Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis.
Watanabe K; Hasegawa Y; Yamashita H; Shimizu K; Ding Y; Abe M; Ohta H; Imagawa K; Hojo K; Maki H; Sonoda H; Sato Y
J Clin Invest; 2004 Oct; 114(7):898-907. PubMed ID: 15467828
[TBL] [Abstract][Full Text] [Related]
55. Anti-angiogenic actions of pyrrolidine dithiocarbamate, a nuclear factor kappa B inhibitor.
Morais C; Gobe G; Johnson DW; Healy H
Angiogenesis; 2009; 12(4):365-79. PubMed ID: 19882112
[TBL] [Abstract][Full Text] [Related]
56. Thalidomide attenuates nitric oxide mediated angiogenesis by blocking migration of endothelial cells.
Tamilarasan KP; Kolluru GK; Rajaram M; Indhumathy M; Saranya R; Chatterjee S
BMC Cell Biol; 2006 Apr; 7():17. PubMed ID: 16584574
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and evaluation of nicotinamide derivative as anti-angiogenic agents.
Choi HE; Choi JH; Lee JY; Kim JH; Kim JH; Lee JK; Kim GI; Park Y; Chi YH; Paik SH; Lee JH; Lee KT
Bioorg Med Chem Lett; 2013 Apr; 23(7):2083-8. PubMed ID: 23453071
[TBL] [Abstract][Full Text] [Related]
58. Serum response factor is a critical requirement for VEGF signaling in endothelial cells and VEGF-induced angiogenesis.
Chai J; Jones MK; Tarnawski AS
FASEB J; 2004 Aug; 18(11):1264-6. PubMed ID: 15180964
[TBL] [Abstract][Full Text] [Related]
59. Endothelial cell metabolism in normal and diseased vasculature.
Eelen G; de Zeeuw P; Simons M; Carmeliet P
Circ Res; 2015 Mar; 116(7):1231-44. PubMed ID: 25814684
[TBL] [Abstract][Full Text] [Related]
60. High glucose-induced jagged 1 in endothelial cells disturbs notch signaling for angiogenesis: a novel mechanism of diabetic vasculopathy.
Yoon CH; Choi YE; Koh SJ; Choi JI; Park YB; Kim HS
J Mol Cell Cardiol; 2014 Apr; 69():52-66. PubMed ID: 24361239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
